Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
An editorial discussing the extrapolation of PCI benefits to asymptomatic patients with stable coronary artery disease.
Treatments are designed to make people feel better or live longer. Percutaneous coronary intervention (PCI) is effective at reducing angina in patients with symptomatic coronary artery disease and at reducing mortality in patients who have acute myocardial infarction with ST-segment elevation and in those who have high-risk acute coronary syndromes without ST-segment elevation.1 Such successes have often been extrapolated in support of more widespread use of PCI in patients with stable coronary artery disease in hopes of reducing subsequent cardiac events.With the increasing availability of noninvasive imaging of coronary artery disease, asymptomatic patients are often referred for PCI. But . . .
No takes yet. Share an insight, caveat, or question.
Hochman et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: